Report title: ANALYSIS OF DIABETES IN JAPAN - INTRODUCTION
from TF Market Research
27 page report published Aug 19, 2002

Price $1,080.00 available for immediate download
This report is also available for purchase on a per-page basis.
Report Overview
 
Purchase by Section
 
About TF Market Research

Source: REUTERS BUSINESS INSIGHT
Geographic Regions: ASIAN CONTINENT, JAPAN
Industries: HEALTH CARE, PHARMACEUTICALS
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
CHAPTER 1 INTRODUCTION13
Current and future prevalence of diabetes41
Impact of Diabetes on Cardiovascular Risk61
Mechanism of increased cardiovascular risk61
Insulin resistance syndrome71
Diabetes and hypertension: A lethal combination91
Hypertension and insulin resistance91
Type 1 diabetics91
Type 2 diabetics101
Obesity111
Current and future prevalence of diabetic hypertension111
Prevalence of diabetic hypertension in the seven major markets 2001111
Increased risk associated with diabetic hypertension131
Commercial implications141
Increased awareness of diabetes drives market growth152
Focus on diabetes prevention and CVD risk reduction171
Companies taking the lead182
Novarits201
NAVIGATOR trial: Starlix (nateglinide) and Diovan (valsartan)201
Study protocol201
Expanding patient potential through early intervention211
Aventis221
DREAM trial: Altace (ramipril) and Avandia (rosiglitazone)221
GlaxoSmithKline231
Avandia (rosiglitazone) for the prevention of cardiovascular disease231
Clinical trials231
Companies facing unexploited opportunities241
Takeda251
Sankyo251
Bristol-Myers Squibb261
AstraZeneca261
Looking Ahead271

Price: $1,080.00



  Get FREE Research

Sign up here to receive email alerts for FREE Research from Alacra Partners!


  Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.